Portfolio company
Ab&B Bio-Tech
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops human vaccines, including quadrivalent influenza subunit and pneumococcal polysaccharide products, for children, adults and elderly patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vicebio
This biopharmaceutical company develops multivalent vaccines for respiratory viral infections targeting older adults and immunocompromised patients.
Abacus Bioscience
This company develops active immunotherapies to treat cancer and chronic infections for patients requiring advanced medical treatments.
Eubiologics
This biopharmaceutical company manufactures vaccines for global health organisations and provides contract research and manufacturing services to the biotechnology industry.
GlycoVaxyn
This biotechnology company develops bioconjugate vaccines for pharmaceutical partners to prevent and treat bacterial infections.
Vaxdyn
Vaxdyn develops multivalent vaccines to prevent antibiotic-resistant bacterial infections for high-risk populations, including hospital patients and those with chronic diseases.
na
This company develops potentiated vaccines for governments and healthcare providers to enhance global immunization and ensure medicine is available for children.
GIVAX
This biotechnology company develops oral mucosal vaccines to protect children and adults against gastrointestinal diseases like rotavirus and norovirus.
Applikon Biotechnology
This company develops bioreactor systems and bioprocess software for biopharmaceutical and biotechnology customers to research and produce vaccines and medicines.
